Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) having become th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateos-Olivares, Milagros, García-Onrubia, Luis, Valentín-Bravo, Fco. Javier, González-Sarmiento, Rogelio, Lopez-Galvez, Maribel, Pastor, J. Carlos, Usategui-Martín, Ricardo, Pastor-Idoate, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307715/
https://www.ncbi.nlm.nih.gov/pubmed/34359853
http://dx.doi.org/10.3390/cells10071683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307715/
https://www.ncbi.nlm.nih.gov/pubmed/34359853
http://dx.doi.org/10.3390/cells10071683

Ejemplares similares